Total Liabilities: The total value of all possible claims against the corporation.
Cytosorbents Corporation (CTSO) had Total Liabilities of $38.28M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$9.23M |
|
$-5.50M |
|
$2.43M |
|
$6.80M |
|
$13.62M |
|
$-4.38M |
|
$-1.11M |
|
$-5.50M |
|
$-5.50M |
|
$-5.50M |
|
$-5.50M |
|
$-5.50M |
|
$-5.50M |
|
$-4.38M |
|
$-3.75M |
|
62.23M |
|
62.23M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$20.63M |
|
$7.82M |
|
$23.55M |
|
$44.18M |
|
$9.71M |
|
$16.67M |
|
$28.57M |
|
|
Total Liabilities |
$38.28M |
$5.90M |
|
$2.68M |
|
$5.90M |
|
62.80M |
|
| Cash Flow Statement Financials | |
$-12.38M |
|
$-0.41M |
|
$9.31M |
|
$9.76M |
|
$7.77M |
|
$-1.99M |
|
$2.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
0.74 |
|
2.82 |
|
73.68% |
|
-47.49% |
|
-47.49% |
|
-- |
|
-59.53% |
|
-59.53% |
|
$-12.46M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.46 |
|
1.22 |
|
73.59 |
|
-93.12% |
|
-205.33% |
|
-12.44% |
|
-24.35% |
|
$0.09 |
|
$-0.20 |
|
$-0.20 |
|